New independent board members with experience in AI infrastructure and the evaluation of entrepreneurial ventures added to form a special committee Special committee to evaluate merits of ...

BOULDER, Colo., July 09, 2025 (GLOBE NEWSWIRE) -- Auddia Inc. (NASDAQ: AUUD) (NASDAQ: AUUDW) (“Auddia” or the “Company”), today announced that Jeff Thramann has succeeded Michael Lawless as CEO of ...

Genentech Provides Update on FDA Advisory Committee Meeting on Columvi Combination for People With Relapsed or Refractory Diffuse Large B-cell Lymphoma - Columvi is the first bispecific antibody to ...

Please provide your email address to receive an email when new articles are posted on . The FDA Endocrinologic and Metabolic Drugs Advisory Committee voted 13-7 for approval of the novel combination ...

Actavis plc (NYSE: ACT) today confirmed that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) has voted to recommend against approval of Actavis' ...

- Columvi is the first bispecific antibody to show a statistically significant and clinically meaningful 41% survival benefit in R/R DLBCL in the Phase III STARGLO study - - There is an urgent need ...

The appraisal committee met 3 times to consider evidence submitted by Janssen–Cilag, a review of this submission by the evidence review group (ERG), and responses from stakeholders. See the committee ...

The appraisal committee reviewed the data available on the clinical and cost effectiveness of cobimetinib in combination with vemurafenib, having considered evidence on the nature of advanced ...

New independent board members with experience in AI infrastructure and the evaluation of entrepreneurial ventures added to form a special committee Special committee to evaluate merits of ...

China's President Xi Jinping during a meeting at the Great Hall of the People in Beijing REUTERS China’s top leaders recently concluded the biggest government meeting to date under the leadership of ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...